Novolog (Pharm-Up 1966) Balance Sheet Health
Financial Health criteria checks 5/6
Novolog (Pharm-Up 1966) has a total shareholder equity of ₪394.1M and total debt of ₪699.0K, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are ₪2.8B and ₪2.4B respectively. Novolog (Pharm-Up 1966)'s EBIT is ₪53.8M making its interest coverage ratio 35.6. It has cash and short-term investments of ₪198.9M.
Key information
0.2%
Debt to equity ratio
₪699.00k
Debt
| Interest coverage ratio | 35.6x |
| Cash | ₪198.92m |
| Equity | ₪394.06m |
| Total liabilities | ₪2.39b |
| Total assets | ₪2.78b |
Recent financial health updates
No updates
Recent updates
Estimating The Fair Value Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Nov 05
Be Wary Of Novolog (Pharm-Up 1966) (TLV:NVLG) And Its Returns On Capital
Jul 25I Ran A Stock Scan For Earnings Growth And Novolog (Pharm-Up 1966) (TLV:NVLG) Passed With Ease
May 07Read This Before Buying Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) For Its Dividend
Apr 14Novolog (Pharm-Up 1966)'s (TLV:NVLG) Earnings Are Of Questionable Quality
Mar 24Novolog (Pharm-Up 1966) Ltd's (TLV:NVLG) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Mar 09How Much Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Do Insiders Own?
Feb 15
Update: Novolog (Pharm-Up 1966) (TLV:NVLG) Stock Gained 88% In The Last Three Years
Jan 25How Much Is Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) CEO Getting Paid?
Dec 29With EPS Growth And More, Novolog (Pharm-Up 1966) (TLV:NVLG) Is Interesting
Dec 08Financial Position Analysis
Short Term Liabilities: NVLG's short term assets (₪2.1B) do not cover its short term liabilities (₪2.2B).
Long Term Liabilities: NVLG's short term assets (₪2.1B) exceed its long term liabilities (₪201.6M).
Debt to Equity History and Analysis
Debt Level: NVLG has more cash than its total debt.
Reducing Debt: NVLG's debt to equity ratio has reduced from 0.6% to 0.2% over the past 5 years.
Debt Coverage: NVLG's debt is well covered by operating cash flow (21822.3%).
Interest Coverage: NVLG's interest payments on its debt are well covered by EBIT (35.6x coverage).